메뉴 건너뛰기
AIDS Patient Care and STDs
Volumn 12, Issue 12, 1998, Pages 903-906
Successful treatment of idiopathic colitis and proctitis using thalidomide in persons infected with Human Immunodeficiency Virus
Author keywords

[No Author keywords available]
Indexed keywords

THALIDOMIDE;
EID: 0032438585     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.903     Document Type: Article
Times cited : (8)
References (10)
  • 1
    • 0026512401 scopus 로고
    • Nonspecific proctitis: Association with human immunodeficiency virus infection in homosexual men
    • Law CLH, Quassim M, Cunningham AL, Mulhall B, Grierson JM. Nonspecific proctitis: Association with human immunodeficiency virus infection in homosexual men. J Infect Dis 1992;165:150-154.
    • (1992) J Infect Dis , vol.165 , pp. 150-154
    • Law, C.L.H.1    Quassim, M.2    Cunningham, A.L.3    Mulhall, B.4    Grierson, J.M.5
  • 2
    • 0028297273 scopus 로고
    • Idiopathic anorectal ulceration in patients with human immunodeficiency virus infection
    • Wilcox CM, Schwartz DA. Idiopathic anorectal ulceration in patients with human immunodeficiency virus infection. Am J Gastroenterol 1994;89:599-603.
    • (1994) Am J Gastroenterol , vol.89 , pp. 599-603
    • Wilcox, C.M.1    Schwartz, D.A.2
  • 3
    • 0027392647 scopus 로고
    • Thalidomide for severe apthous ulceration in patients with human immunodeficiency virus (HIV) infection
    • Ghigliotti G, Repetto T, Farris A, Roy M, DeMarch R. Thalidomide for severe apthous ulceration in patients with human immunodeficiency virus (HIV) infection. J Am Acad Dermatol 1993;28:271-272.
    • (1993) J Am Acad Dermatol , vol.28 , pp. 271-272
    • Ghigliotti, G.1    Repetto, T.2    Farris, A.3    Roy, M.4    DeMarch, R.5
  • 4
    • 0028836889 scopus 로고
    • Thalidomide as treatment of refractory apthous ulceration related to human immunodeficiency virus infection
    • Paterson DL, Georghiou PR, Alloworth AM, Kemp RJ. Thalidomide as treatment of refractory apthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis 1995;20:250-254.
    • (1995) Clin Infect Dis , vol.20 , pp. 250-254
    • Paterson, D.L.1    Georghiou, P.R.2    Alloworth, A.M.3    Kemp, R.J.4
  • 5
    • 0031012923 scopus 로고    scopus 로고
    • Thalidomide for treatment of oral apthous ulcers in patients with human immunodeficiency virus: Case report and review
    • Ball SC, Sepkowitz KA, Jacobs JL. Thalidomide for treatment of oral apthous ulcers in patients with human immunodeficiency virus: Case report and review. Am J Gastroenterol 1996;92:169-170.
    • (1996) Am J Gastroenterol , vol.92 , pp. 169-170
    • Ball, S.C.1    Sepkowitz, K.A.2    Jacobs, J.L.3
  • 7
    • 0026758726 scopus 로고
    • Thalidomide in painful AIDS-associated proctitis
    • Georghious PR, Alloworth AM. Thalidomide in painful AIDS-associated proctitis. J Infect Dis 1992;166:939-940.
    • (1992) J Infect Dis , vol.166 , pp. 939-940
    • Georghious, P.R.1    Alloworth, A.M.2
  • 8
    • 0030732493 scopus 로고    scopus 로고
    • Idiopathic colonic inflammation in AIDS: An open trial of prednisone
    • Gopal DV, Hassaram S, Marcon NE, Kamdel G. Idiopathic colonic inflammation in AIDS: an open trial of prednisone. Am J Gastroenterol 1997;92:2237-2240.
    • (1997) Am J Gastroenterol , vol.92 , pp. 2237-2240
    • Gopal, D.V.1    Hassaram, S.2    Marcon, N.E.3    Kamdel, G.4
  • 9
    • 0030043011 scopus 로고    scopus 로고
    • Thalidomide in diseases associated with human immunodeficiency virus infection
    • Minor JR, Piscitelli SC. Thalidomide in diseases associated with human immunodeficiency virus infection. Am J Health-Syst Pharm 1996;53:429-431.
    • (1996) Am J Health-Syst Pharm , vol.53 , pp. 429-431
    • Minor, J.R.1    Piscitelli, S.C.2
  • 10
    • 0027230553 scopus 로고
    • Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
    • Moreria A, Sampaio E, Zmuidzinas A, Frindt P, Smith K, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993;177:1675-1680.
    • (1993) J Exp Med , vol.177 , pp. 1675-1680
    • Moreria, A.1    Sampaio, E.2    Zmuidzinas, A.3    Frindt, P.4    Smith, K.5    Kaplan, G.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.